uso de inhibidores de la bomba de
uso de inhibidores de la bomba de
uso de inhibidores de la bomba de
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
247Summary of Product Characteristics - Pariet 10mg & 20mg. [Internet] Disponible en:http://emc.medicines.org.uk (consultado el 5-3-2011).248 Pecora PG, Kap<strong>la</strong>n B. Corticosteroids and ulcers: is there an association? Ann Pharmacother. 1996;30(7-8):870-2. Disponible en: http://www.hubmed.org/disp<strong>la</strong>y.cgi?uids=8826575 (consultado el 21-12-2011).249 Conn HO, Blitzer B. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med.1976; 294: 473-479. 31.250 Messer J , Reitman D , SA, Sacos , H Smith Jr , Chalmers TC. Asociación <strong>de</strong> <strong>la</strong> terapiaadrenocorticosteroid y <strong>la</strong> enfermedad péptica ulcerosa. J Med N Engl. 1983;309 (1) :21-4.251 Fernán<strong>de</strong>z-Bal<strong>la</strong>rt JD, Vobecky J, Martí-Henneberg C. Metaanálisis: síntesis e integración <strong>de</strong> losresultados <strong>de</strong> estudios in<strong>de</strong>pendientes en medicina. Med Clin (Barc). 1991; 96: 382-387.252CSK. Antip<strong>la</strong>telet treatment. [Internet] Ing<strong>la</strong>terra 2006 Oct. Disponible en:http://WWW.cks.library.nhs.uk/antip<strong>la</strong>telet_treatment/view_whole_guidance (consultado el 5-3-2011).253 Piper JM, Ray WA and Daugherty JR et al. Corticosteroid use and peptic ulcer disease: role ofnonsteroidal anti-inf<strong>la</strong>mmatory drugs. Ann Intern Med. 1991; 114(9):735-40. Disponible en:http://www.hubmed.org/disp<strong>la</strong>y.cgi?uids=2012355 (consultado el 5-3-2011).254 Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroidtherapy. J Intern Med. 1994;236(6):619-32.255 Feldman M, Das S. NSAIDs (including aspirin). Primary prevention of Gastroduo<strong>de</strong>nal toxicity. Thistopic <strong>la</strong>st update. [Internet] 2011. Disponible en: http://www.uptodate.com/contents/nsaids-includingaspirin-primary-prevention-of-gastroduo<strong>de</strong>nal-toxicity(consultado el 21-12-2011)256 MeReC Briefing. NSAIDs and gastroprotection.[Internet] Ing<strong>la</strong>terra 2002 Oct. Disponible en:http://www.npc.co.uk/MeReC_Briefings/2002/briefing_no_20.pdf).# (consultado el 5-3-2011).257 McGettigan P, Henry D. Cardiovascu<strong>la</strong>r risk and inhibition of cyclooxygenase: a systematic review ofthe observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006.2961633–1644. [PubMed]258 Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, et al. EULAR evi<strong>de</strong>nce-basedrecommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. AnnRheum Dis. 2007;66(12):1560-7. Disponible en:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095301/?tool=pubmed (consultado el 8-3-2011).259 Richard A. Hansen, Ph.D.; Wanzhu Tu, Ph.D.; Jane Wang, Ph.D.; Roberta Ambuehl, B.S.; Clement J.McDonald, M.D.; Michael D. Murray, Pharm.D. .Risk of Adverse Gastrointestinal Events From InhaledCorticosteroids. Pharmacotherapy. 2008;28(11):1325-1334. Disponible en:http://www.medscape.com/viewarticle/583848 (consultado el 8-3-2011).260 Paton C, Nicol Ferrier I. SSRIs and gastrointestinal bleeding Gastroprotection may be justified in somepatients. BMJ. 2005; 331(7516): 529–530.261 De Abajo FJ, Rodriguez AG, Montero D. Association between selective serotonin reuptake inhibitorsand upper gastrointestinal bleeding. BMJ. 1999; 319: 11069.262 Layton D, C<strong>la</strong>rk DW, Pearce GL, Shakir SAW. Is there an association between selective serotoninreuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescriptionevent monitoring in Eng<strong>la</strong>nd. Eur J Clin Pharmacol. 2001; 57: 167-176.110
Change language